The response of patients with AML to ara-C or DAC inversely correlates with SAMHD1 expression levels or activity (Herold et al., 2017a, Oellerich et al., 2019, Rudd et al., 2020, Schneider et al., 2017). This evidence concerns the gene SAMHD1 and acute myeloid leukemia.